Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Composition : Ceftazidime (250mg) + Sulbactam (125mg)
Dosage Form : Injection
Packaging Type : Vial + Water
Packaging : 375mg
Price : ₹55/-
Dimezeft 375 Injection combines Ceftazidime, a third-generation cephalosporin antibiotic, with Sulbactam, a beta-lactamase inhibitor. This combination enhances the activity of Ceftazidime by inhibiting bacterial beta-lactamase enzymes, which otherwise degrade the antibiotic. This makes Dimezeft 375 effective against a broader range of bacterial infections, including those caused by resistant organisms. The combination of Ceftazidime and Sulbactam is particularly effective in treating serious infections caused by Gram-negative bacteria, including Pseudomonas aeruginosa, and some Gram-positive bacteria.
Dimezeft 375 is commonly used to treat infections such as pneumonia, urinary tract infections, skin and soft tissue infections, intra-abdominal infections, and sepsis. It is also effective in treating complicated infections in immunocompromised patients. The injection is administered intravenously or intramuscularly, ensuring rapid and targeted antibacterial action.
Common side effects include nausea, diarrhea, rash, injection site reactions, and changes in liver function tests.
Used for the treatment of severe bacterial infections, including respiratory, urinary, intra-abdominal, and skin infections.
Administer only under medical supervision. Complete the full course of treatment to prevent antibiotic resistance.
Store in a cool, dry place at room temperature below 25°C. Protect from light.
Composition : Ceftazidime (250mg)
Composition : Ceftriaxone (1000mg)
Composition : Ceftriaxone (1000mg) + Sulbactam (500mg)
Composition : Ceftriaxone (125mg) Injection
Composition : Ceftriaxone (250mg)
Composition : Ceftriaxone (250mg) + Sulbactam (125mg)
Composition : Ceftriaxone (250mg) + Tazobactum (31.25mg)
Composition : Ceftriaxone (500mg)
Composition : Ceftriaxone (500mg) + Sulbactam (250mg)
Composition : Cefuroxime (1500mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Strategic Advisory
Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.
View Professional Profile
Start Your Journey
Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!
Quick Navigation